Showing results (111-120 of 183) with videos related to

Sort By:
Pageof 19
Journal for Immunotherapy of Cancer|July 19, 2019
Diverse immunotherapies can effectively treat syngeneic brainstem tumors in the absence of overt toxicityMatthew R Schuelke, Phonphimon Wongthida, Jill Thompson, et al.
Cancer Research|December 20, 2007
Induction of hsp70-mediated Th17 autoimmunity can be exploited as immunotherapy for metastatic prostate cancerTimothy Kottke, Luis Sanchez-Perez, Rosa Maria Diaz, et al.
Agricultural and Forest Entomology|March 22, 2024
Silvopastoral systems benefit invertebrate biodiversity on tropical livestock farms in Caquetá, ColombiaLois Kinneen, María Paula Escobar, Luis Miguel Hernandez, et al.
The Journal of Clinical Investigation|April 6, 2010
Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in miceTimothy Kottke, Geoff Hall, Jose Pulido, et al.
Experimental Cell Research|May 1, 2007
The inhibition of TNF-alpha anti-tumoral properties by blocking antibodies promotes tumor growth in a rat modelNicolas Larmonier, Dominique Cathelin, Claire Larmonier, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 3, 2020
Vesicular Stomatitis Virus Encoding a Destabilized Tumor Antigen Improves Activation of Anti-tumor T Cell ResponsesAmanda L Huff, Laura Evgin, Jill Thompson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 28, 2015
Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune ResponsesKarishma Rajani, Christopher Parrish, Timothy Kottke, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 28, 2011
Precise scheduling of chemotherapy primes VEGF-producing tumors for successful systemic oncolytic virotherapyTimothy Kottke, John Chester, Elizabeth Ilett, et al.
Physiological Reports|August 7, 2025
Transcriptomic time course of skeletal muscle disuse and rehabilitation in middle-aged adultsZachary D Von Ruff, Sean P Kilroe, Erik D Marchant, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 24, 2008
Treg depletion-enhanced IL-2 treatment facilitates therapy of established tumors using systemically delivered oncolytic virusTimothy Kottke, Feorillo Galivo, Phonphimon Wongthida, et al.
Pageof 19